Urine composition in patients with urolithiasis during treatment with magnesium oxide

@article{Tiselius2004UrineCI,
  title={Urine composition in patients with urolithiasis during treatment with magnesium oxide},
  author={H. Tiselius and C. Ahlstrand and L. Larsson},
  journal={Urological Research},
  year={2004},
  volume={8},
  pages={197-200}
}
SummaryFifteen patients with recurrent renal stone formation were treated with 400 mg magnesium oxide daily. Urine composition was analyzed before the start of treatment and after 6–12 months. The urinary excretion of magnesium before and during treatment was 321±120 (mean ±SD) and 409±140 mmol per mol creatinine respectively, a difference that was not statistically significant. Urinary calcium increased from 473±186 to 662±213 mmol per mol creatinine (p<0.05). All patients who increased their… Expand
Evaluating the Effectiveness of Adding Magnesium Chloride to Conventional Protocol of Citrate Alkali Therapy in Children with Urolithiasis
Bioavailability of magnesium from different pharmaceutical formulations
MEDICAL MANAGMENT OF UROLITHIASIS, WHAT OPORTUNITY FOR PHYTOTHERAPY?
Pharmacologic Prophylaxis of Calcium Stones
Practical approach to metabolic evaluation and treatment of the recurrent stone patient.
...
1
2
...

References

SHOWING 1-10 OF 17 REFERENCES
Ionic interaction with bone mineral
...
1
2
...